Eptinezumab-Jjmr

Common brands: Vyepti, Botox, Ubrelvy, Nurtec Odt, Topamax

Top reporter: Lundbeck Pharmaceuticals Llc

Calcitonin Gene-related Peptide Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Acetylcholine Release Inhibitor [EPC]Neuromuscular Blocker [EPC]
8,554
Total Reports
4,102
Serious Reports
55
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.64%)

Patient Demographics

Male
841
Female
5,161

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Eptinezumab-Jjmr.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 2,003
19.7%
2 MIGRAINE 1,413
13.9%
3 HEADACHE 927
9.1%
4 THERAPEUTIC RESPONSE SHORTENED 535
5.3%
5 NAUSEA 525
5.2%
6 FATIGUE 464
4.6%
7 DRUG EFFECT LESS THAN EXPECTED 349
3.4%
8 THROAT IRRITATION 336
3.3%
9 DIZZINESS 324
3.2%
10 PRURITUS 296
2.9%
11 NASAL CONGESTION 240
2.4%
12 HYPERSENSITIVITY 197
1.9%
13 VOMITING 195
1.9%
14 DYSPNOEA 189
1.9%
15 MALAISE 172
1.7%
16 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 159
1.6%
17 CHEST DISCOMFORT 155
1.5%
18 COVID-19 153
1.5%
19 COUGH 150
1.5%
20 RASH 149
1.5%
21 RHINORRHOEA 135
1.3%
22 OFF LABEL USE 134
1.3%
23 OROPHARYNGEAL PAIN 129
1.3%
24 ADVERSE DRUG REACTION 128
1.3%
25 THERAPEUTIC RESPONSE DECREASED 126
1.2%
26 FEELING ABNORMAL 122
1.2%
27 PAIN 120
1.2%
28 PRODUCT DOSE OMISSION ISSUE 117
1.2%
29 THERAPEUTIC RESPONSE DELAYED 117
1.2%
30 NASOPHARYNGITIS 114
1.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.